Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

 

DPhil Students: Carl welcomes informal contacts from students in the following areas:

  • Community-based healthcare problems 
  • Diagnosis, Overdiagnosis and Too much Medicine, 
  • Public understanding of EBM
  • Drug and device regulation 
  • Avoidable Harms 
  • Research methods and regulatory science

Carl Heneghan

BM, BCH, MA, MRCGP, DPhil


Professor of Evidence-Based Medicine

  • Director of CEBM & Programs in EBHC
  • NHS Urgent Care GP
  • NIHR Senior Investigator

Carl Heneghan is a clinical epidemiologist with evidence-based medicine, research methods, and evidence synthesis expertise. 

He has over 400 peer-reviewed publications (current H index 79); published 95 systematic reviews. He is a Contact Editor in the Cochrane Acute Respiratory Infection group and Editor of the Catalogue of Bias.

His work includes investigating drugs and devices, advising governments on regulatory evidence, and working with the media to assess health claims and research on common presenting conditions in primary care.

He has investigated the evidence for antivirals Tamiflu, acute respiratory infections and the transmission of SARs-CoV-2. He has expertise in medical device regulation as well as diagnosis and screening.

Impact projects include the COVID-19 Evidence Service,  anticoagulation care, Primodos & congenital malformations and the harms of transvaginal mesh (see cebm research)

He is a clinical advisor to two UK All Parliamentary Party Group on Surgical Mesh and Hormone Pregnancy Tests, an adviser to the WHO clinical trials registry platform and a founder of the AllTrials campaign; twice he was voted one of the top 100 NHS clinical leaders by the HSJ. In 2018 he was awarded NIHR Senior Investigator status.  

Teaching:

In 2019 he received a lifetime achievement award from Oxford's Medical Science Division for his sustained commitment to education and teaching. He is the Director of the Centre for Evidence-Based Medicine (CEBM), which builds capacity through teaching and training activities. He teaches undergraduates, postgraduates and teachers of EBM, and is Director of Programs in Evidence-Based Health Care,

Dissemination and Media: See find an expert page

Contributor to BBC Radio 4's Inside Health series, regularly podcasts his talks on iTunes to download. He has an active Twitter account @carlheneghan and columnist for the Spectator

Global Centre for Healthcare and Urbanisation (GCHU)

He is co-director of the GCHU based at Kellogg College which has been established to foster a better understanding of the interaction between healthcare and urbanisation. 

Conflicts of interest and payments:

He holds grant funding from the NIHR School of Primary Care Research, the NIHR BRC Oxford, and the World Health Organization for a series of Living rapid reviews on the modes of transmission of SARs-CoV-2 reference WHO registration No2020/1077093. He has received financial remuneration from an asbestos case and given legal advice on mesh and hormone pregnancy tests cases. He has received expenses and fees for his media work including occasional payments from BBC Radio 4 Inside Health and The Spectator. He receives expenses for teaching EBM and is also paid for his GP work in NHS out of hours (contract Oxford Health NHS Foundation Trust). He has also received income from the publication of a series of toolkit books for appraising treatment recommendations in non-NHS settings and for undertaking evidence reviews. He is an advisor to Collateral Global, the Sir James Mackenzie Institute for Early Diagnosis at St Andrew's University, the WHO's International Clinical Trials Registry Platform (ICTRP) and is a member of the Board of Preventing Overdiagnosis.